Acanthosis Nigricans
Understand Acanthosis Nigricans (AN), a skin condition characterized by dark, velvety skin patches. Learn about AN diagnosis, clinical documentation, and medical coding including ICD-10 codes. Find information on associated conditions, treatment options, and healthcare provider resources for Acanthosis Nigricans and dark skin patches.
Skin condition causing dark, thickened, velvety patches, often in body folds.
Dark, velvety skin in armpits, neck, groin; skin tags; sometimes itching.
Endocrinology, Dermatology, Primary Care; often linked to insulin resistance.
ICD-10 Code Families
Complete code families applicable to L83
When to use each related code
| Description | When to use |
|---|---|
| Dark, thickened skin patches, often velvety. | Use for velvety hyperpigmentation, especially flexural areas. Consider insulin resistance, obesity, malignancy. |
| Benign, localized brown birthmark. | Use for well-defined, uniformly pigmented macules/patches present at birth or early childhood. Exclude melanoma. |
| Dark spots/patches due to sun exposure. | Use for hyperpigmented macules/patches on sun-exposed skin. Consider photoaging, UV damage. Exclude melanoma. |
Best-practice checklist
- ✓Document location, size, and color of AN lesions.
- ✓Describe skin texture (e.g., velvety, hyperkeratotic).
- ✓Note associated signs like skin tags or hyperpigmentation.
- ✓Record patient history, including medications and comorbidities.
- ✓Specify if AN is benign or associated with underlying conditions.
Common pitfalls to avoid
Coding AN without specifying benign, malignant, or drug-induced creates unspecified diagnosis risks, impacting CDI and reimbursement.
Miscoding AN for other hyperpigmentation disorders due to similar symptoms leads to inaccurate data for quality reporting and healthcare compliance.
Failing to code the underlying obesity when present with AN leads to incomplete documentation, affecting risk adjustment and medical coding accuracy.
Best-practice tips
- 01Improve AN documentation: Detail skin changes, locations, severity.
- 02Code AN accurately: Use ICD-10 L81.1, link to underlying cause.
- 03Address AN comorbidities: Screen for diabetes, hormonal imbalances.
- 04Patient education for AN: Promote healthy weight, skin care.
- 05AN clinical relevance: Document relation to medications, family history.
Step-by-step checklist
- 1
Verify velvety, dark skin patches, especially neck, axilla, groin (ICD-10: L81.1)
- 2
Assess patient BMI and waist circumference for obesity indicators
- 3
Screen for diabetes with fasting glucose or A1C (ICD-10: E11-E14)
- 4
Consider malignancy if sudden onset or rapid progression (ICD-10: C00-C97)
Ready-to-paste narrative
Patient presents with complaints consistent with acanthosis nigricans (AN), characterized by hyperpigmented, velvety skin thickening. Areas affected include the neck, axillae, and inguinal folds. The patient denies pruritus or pain associated with the lesions. Differential diagnosis includes pseudoacanthosis nigricans, insulin resistance, obesity-related acanthosis nigricans, and malignant acanthosis nigricans. Family history was reviewed for endocrinopathies and malignancies. Current medications were assessed for potential drug-induced acanthosis nigricans. Physical examination reveals dark skin patches with a classic velvety texture. Laboratory testing, including fasting glucose and insulin levels, is ordered to evaluate for underlying metabolic disorders like diabetes and insulin resistance, a common association with AN. Further investigation for malignancy may be warranted depending on laboratory results and patient history. Patient education provided on acanthosis nigricans symptoms, causes, and potential link to systemic diseases. Treatment plan focuses on addressing any underlying conditions like diabetes or obesity. Follow-up scheduled to monitor the skin changes and discuss management strategies, which may include topical treatments for cosmetic improvement if deemed necessary. ICD-10 code L81.1 and relevant CPT codes for evaluation and management will be documented for medical billing and coding purposes.
Common questions and answers
What are the most effective diagnostic approaches for differentiating Acanthosis Nigricans from other hyperpigmented skin conditions in adults?+
Differentiating Acanthosis Nigricans (AN) from other hyperpigmented skin conditions like tinea versicolor or melasma requires a multifaceted approach. Clinical examination focusing on the characteristic velvety texture and location (typically flexural areas like the neck, axillae, and groin) is crucial. While AN itself is often a clinical diagnosis, consider further investigations to identify underlying causes. Fasting blood glucose and insulin levels are essential to assess for insulin resistance and diabetes. If an underlying malignancy is suspected based on rapid onset, unusual distribution, or severe symptoms, a thorough history, physical examination, and potentially biopsies for histopathological evaluation are necessary. Explore how age, associated symptoms, and family history can also inform the diagnostic process for Acanthosis Nigricans.
How can I effectively manage Acanthosis Nigricans in patients with underlying insulin resistance, considering both pharmacological and lifestyle interventions?+
Managing Acanthosis Nigricans (AN) in patients with insulin resistance requires a comprehensive strategy addressing the underlying metabolic issue. Lifestyle modifications, including weight loss through dietary changes and regular exercise, are first-line interventions. These interventions can significantly improve insulin sensitivity and may lessen the severity of AN. Pharmacological interventions, such as metformin, may be considered for patients with impaired glucose tolerance or type 2 diabetes. Additionally, topical treatments like retinoids or keratolytics might be used to address the cosmetic concerns associated with AN. Consider implementing regular monitoring of fasting blood glucose and HbA1c levels to assess the effectiveness of the chosen management plan. For some patients, exploring other contributing factors, such as medications or endocrine disorders, may be warranted.
What are the key clinical features and associated conditions that raise suspicion for malignant Acanthosis Nigricans, warranting urgent referral to a specialist?+
Malignant Acanthosis Nigricans, while rare, necessitates prompt recognition and referral. Rapid onset, particularly in older adults with no history of AN, should raise suspicion. Atypical locations, such as the palms, soles, mucous membranes, or widespread distribution, are also concerning features. Additional red flags include prominent skin thickening, severe pruritus, and the presence of other cutaneous manifestations like Leser-Trelat sign (multiple seborrheic keratoses). Any association with new-onset gastrointestinal symptoms, weight loss, or lymphadenopathy warrants urgent investigation for an underlying malignancy. Learn more about the specific types of cancers commonly associated with malignant Acanthosis Nigricans and the importance of early detection for improved patient outcomes.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.